Pfizer and its partner BioNTech have asked the Food and Drug Administration to allow their COVID vaccine to be used in children 4 years to 6 months old.
Author: Karen Weintraub and Elizabeth Weise, USA TODAY
Public health in America at a breaking point. The question is now ‘Can it recover?’
Business as usual won’t be enough to combat the next public health crisis, experts say. The U.S. must tackle long-standing health problems, too.
South Africa finds omicron ‘highly transmissible’ and more resistant to COVID-19 vaccines
The omicron variant is substantially more contagious and reduces the effectiveness of COVID-19 vaccines, according to a new South Africa study.
‘Spreading at a rate we have not seen’ – Omicron more resistant to COVID-19 vaccines
The omicron variant is substantially more contagious and reduces the effectiveness of COVID-19 vaccines, according to a new South Africa study.
CDC panel recommends Pfizer COVID-19 vaccine for kids 5-11, shots expected to roll out this week
CDC experts find the benefits of Pfizer’s COVID-19 vaccine for kids 5 -11 outweigh risks. Once the director gives his final OK, shots are likely to begin this week.
FDA committee moves Pfizer-BioNTech COVID-19 vaccine closer to use for children ages 5-11
In children ages 5-11, the Pfizer-BioNTech vaccine was more than 90% protective against contracting symptomatic COVID-19, according to company data.
CDC endorses COVID-19 vaccine boosters for people 65 and older, high-risk patients
The CDC endorsed booster shots for millions of older and high-risk Americans, opening a major new phase in the U.S vaccination drive against COVID-19.
Pfizer-BioNTech COVID-19 vaccine becomes first to win FDA’s full approval, paving way for boosters, mandates
The FDA’s decision to fully license the Pfizer-BioNTech COVID-19 vaccine is expected to trigger more mandates and allow marketing of the shot.
Deleted gene sequences confirm coronavirus circulated before Wuhan seafood market
A new report does not answer whether the SARS-CoV-2 virus jumped directly from animals to people or was accidently leaked from a Chinese research lab.
New York launches nation’s first ‘vaccine passports.’ Others are working on similar ideas, but many details must be worked out.
New York’s new Excelsior Pass is part of a growing but disjointed effort to provide vaccine ‘passports’ or certifications useful for safe gatherings.